Impaired antibody response to COVID-19 vaccination in blood cancer and arthritis patients after treatment with widely used drug

Certain blood cancer and arthritis patients have a significantly reduced antibody response to double COVID-19 vaccination in the first six months of being treated with a widely used drug, reveals a new study. The research, published in journal Clinical & Experimental Immunology, was carried out by experts across the Universities of Birmingham and Wolverhampton, The Royal … Continue reading “Impaired antibody response to COVID-19 vaccination in blood cancer and arthritis patients after treatment with widely used drug”

Matoke Holdings to conduct formulation research at the BioHub Birmingham®

Matoke Holdings Ltd has joined the community of biomedical R&D companies located in the BioHub Birmingham® and announced the next phase of development for its Reactive Oxygen® technology, which is expected to deliver a major breakthrough in acute, surgical and chronic wound management. Matoke Holdings is well-known for pioneering the delivery of its patented Reactive … Continue reading “Matoke Holdings to conduct formulation research at the BioHub Birmingham®”